MedPath

Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Healthy Toddlers

Phase 1
Completed
Conditions
Healthy
Registration Number
NCT00387569
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Brief Summary

A study to assess the safety of an investigational meningitis vaccine in toddlers and their immune response to it.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Local and systemic reactions through 14 days post-injection; Vaccinations at 0,1,6 monthsVaccinations at 0,1,6 months
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.